Senior insider sale
Chief Financial Officer at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$551.0K
65K shares
What this filing means
PIEPER STEVEN plans to sell 65K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $551.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2026ACC: 0001950047-26-008033
Officer· Chief Financial Officer
Since Oct 2021
65K
Shares to sell
$551.0K
Approx. market value
20K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/3/2025
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2025 | Restricted Stock Units N/A | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
27.60K
Market value
$235.3K
7/7/2026
—Completed
Units to sell
17.40K
Market value
$147.9K
7/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$167.8K
8/12/2026
Total
Units
65K
Value
$551.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/7/2026 | 27.60K | $235.3K | — | Completed |
7/6/2026 | 17.40K | $147.9K | — | Completed |
| Planned — Approximate Date | ||||
8/12/2026 | 20K | $167.8K | NASDAQ | Planned |
| Total | 65K | $551.0K | ||